You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MYCELEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Mycelex

A generic version of MYCELEX was approved as clotrimazole by P AND L on July 16th, 1993.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MYCELEX?
  • What are the global sales for MYCELEX?
  • What is Average Wholesale Price for MYCELEX?
Summary for MYCELEX
Drug patent expirations by year for MYCELEX
Recent Clinical Trials for MYCELEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Weill Medical College of Cornell UniversityPhase 4
OnxeoPhase 3
Boehringer IngelheimPhase 3

See all MYCELEX clinical trials

US Patents and Regulatory Information for MYCELEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc MYCELEX clotrimazole CREAM;TOPICAL 018183-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc MYCELEX-7 clotrimazole CREAM;VAGINAL 018230-002 Dec 26, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole TROCHE/LOZENGE;ORAL 018713-001 Jun 17, 1983 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc MYCELEX-7 COMBINATION PACK clotrimazole CREAM, TABLET;TOPICAL, VAGINAL 020389-002 Jun 23, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc MYCELEX-7 clotrimazole TABLET;VAGINAL 018182-002 Dec 26, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MYCELEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc MYCELEX clotrimazole CREAM;TOPICAL 018183-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole TROCHE/LOZENGE;ORAL 018713-001 Jun 17, 1983 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole TROCHE/LOZENGE;ORAL 018713-001 Jun 17, 1983 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole TROCHE/LOZENGE;ORAL 018713-001 Jun 17, 1983 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MYCELEX

See the table below for patents covering MYCELEX around the world.

Country Patent Number Title Estimated Expiration
Switzerland 560691 N-tritylimidazoles plant fungicides ⤷  Sign Up
Norway 131987 ⤷  Sign Up
Norway 124110 ⤷  Sign Up
Switzerland 554868 VERFAHREN ZUR HERSTELLUNG VON N-TRITYL-IMIDAZOLEN. ⤷  Sign Up
Yugoslavia 215168 ⤷  Sign Up
Canada 938611 PROCESS FOR THE PREPARATION OF N-TRITYL-IMIDAZOLES ⤷  Sign Up
Switzerland 517100 Verfahren zur Herstellung von N-Trityl-imidazolen ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.